Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul Waring
Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer
Clinical Cancer Research
Cancer Research
Oncology
Genetic and Histopathologic Evaluation ofBRCA1andBRCA2DNA Sequence Variants of Unknown Clinical Significance
Cancer Research
Cancer Research
Oncology
Related publications
RIPK3 Expression as a Potential Predictive and Prognostic Marker in Metastatic Colon Cancer
Clinical and Investigative Medicine
Medicine
Prospective Evaluation of a 12-Gene Assay on Patient Treatment Decisions and Physician Confidence in Mismatch Repair Proficient Stage IIA Colon Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients
Oncologist
Cancer Research
Medicine
Oncology
L1TD1 - A Prognostic Marker for Colon Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Expression of Aquaporin-1 Is a Poor Prognostic Factor for Stage II and III Colon Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Identification of a Sixteen-microRNA Signature as Prognostic Biomarker for Stage II and III Colon Cancer
Oncotarget
Oncology
Prognostic and Predictive Role of DNA Mismatch Repair Status in Stage II‐III Colorectal Cancer: A Systematic Review and Meta‐Analysis
Clinical Genetics
Genetics
P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer
Scientific Reports
Multidisciplinary
